Can ketones help rescue brain fuel supply in later life? Implications for cognitive health during aging and the treatment of alzheimer’s disease

Frontiers in Molecular Neuroscience

Volumn 9, Issue JUL, 2016, Pages

  Cunnane, Stephen C ^a,b   Courchesne Loyer, Alexandre ^a,b   Vandenberghe, Camille ^a,b   St Pierre, Valérie ^a,b   Fortier, Mélanie ^a   Hennebelle, Marie ^a   Croteau, Etienne ^a   Bocti, Christian ^a,b   Fulop, Tamas ^a,b   Castellano, Christian Alexandre ^a  

^a Research Center on Aging   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Acetoacetate; Aging; Alzheimer s disease; Beta hydroxybutyrate; Glucose; Ketone; Medium chain fatty acid; Mild cognitive impairment

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; APOLIPOPROTEIN E4; KETONE; PRESENILIN 1;

AGING; ALZHEIMER DISEASE; ARTICLE; COGNITION; COGNITIVE DEFECT; ENERGY METABOLISM; EXERCISE; GLUCOSE BRAIN LEVEL; GLUCOSE INTAKE; GLUCOSE TRANSPORT; HUMAN; HYPOGLYCEMIA; INSULIN RESISTANCE; KETOACIDOSIS; LIFESTYLE AND RELATED PHENOMENA; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; POSITRON EMISSION TOMOGRAPHY; RISK FACTOR; SEIZURE;

EID: 84984623335     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2016.00053     Document Type: Article

References (140)

1. Acheson, K. J., Gremaud, G., Meirim, I., Montigon, F., Krebs, Y., Fay, L. B., et al. (2004). Metabolic effects of caffeine in humans: Lipid oxidation or futile cycling?. Am. J. Clin. Nutr. 79, 40-46.
2. Adam, P. A., Raiha, N., Rahiala, E. L., and Kekomaki, M. (1975). Oxidation of glucose and D-B-OH-butyrate by the early human fetal brain. Acta Paediatr. Scand. 64, 17-24. doi: 10.1111/j.1651-2227.1975.tb04375.x
3. Amatniek, J. C., Hauser, W. A., DelCastillo-Castaneda, C., Jacobs, D. M., Marder, K., Bell, K., et al. (2006). Incidence and predictors of seizures in patients with Alzheimer’s disease. Epilepsia 47, 867-872. doi: 10.1111/j.1528-1167.2006.00554.x
4. Amiel, S. A., Archibald, H. R., Chusney, G., Williams, A. J., and Gale, E. A. (1991). Ketone infusion lowers hormonal responses to hypoglycaemia: Evidence for acute cerebral utilization of a non-glucose fuel. Clin. Sci. (Lond). 81, 189-194. doi: 10.1042/cs0810189
5. Auestad, N., Korsak, R. A., Morrow, J. W., and Edmond, J. (1991). Fatty acid oxidation and ketogenesis by astrocytes in primary culture. J. Neurochem. 56, 1376-1386. doi: 10.1111/j.1471-4159.1991.tb11435.x
6. Avogaro, A., Nosadini, R., Bier, D. M., Cobelli, C., Toffolo, G., Doria, A., et al. (1990). Ketone body kinetics in vivo using simultaneous administration of acetoacetate and 3-hydroxybutyrate labelled with stable isotopes. Acta Diabetol Lat. 27, 41-51. doi: 10.1007/BF02624721
7. Bach, A. C., and Babayan, V. K. (1982). Medium-chain triglycerides: An update. Am. J. Clin. Nutr. 36, 950-962.
8. Baker, L. D., Cross, D. J., Minoshima, S., Belongia, D., Watson, G. S., and Craft, S. (2011). Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch. Neurol. 68, 51-57. doi: 10.1001/archneurol.2010.225
9. Balasse, E. O., and Fery, F. (1989). Ketone body production and disposal: Effects of fasting, diabetes, and exercise. Diabetes Metab. Rev. 5, 247-270. doi: 10.1002/dmr.5610050304
10. Balasse, E. O., Fery, F., and Neef, M. A. (1978). Changes induced by exercise in rates of turnover and oxidation of ketone bodies in fasting man. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 44, 5-11.
11. Bekesi, A., and Williamson, D. H. (1990). An explanation for ketogenesis by the intestine of the suckling rat: The presence of an active hydroxymethylglutarylcoenzyme A pathway. Biol. Neonate 58, 160-165. doi: 10.1159/000243256
12. Benson, D. F., Kuhl, D. E., Hawkins, R. A., Phelps, M. E., Cummings, J. L., and Tsai, S. Y. (1983). The fluorodeoxyglucose 18F scan in Alzheimer’s disease and multi-infarct dementia. Arch. Neurol. 40, 711-714. doi: 10.1001/archneur.1983.04050110029003
13. Bickerton, A. S., Roberts, R., Fielding, B. A., Tornqvist, H., Blaak, E. E., Wagenmakers, A. J., et al. (2008). Adipose tissue fatty acid metabolism in insulin-resistant men. Diabetologia 51, 1466-1474. doi: 10.1007/s00125-008-1040-x
14. Blass, J. P. (2008). A new approach to treating Alzheimer’s disease. Ann. N. Y. Acad. Sci. 1147, 122-128. doi: 10.1196/annals.1427.022
15. Blomqvist, G., Alvarsson, M., Grill, V., Von Heijne, G., Ingvar, M., Thorell, J. O., et al. (2002). Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients Am. J. Physiol. Endocrinol. Metab. 283, E20-E28. doi: 10.1152/ajpendo.00294.2001
16. Blomqvist, G., Thorell, J. O., Ingvar, M., Grill, V.,Widen, L., and Stone-Elander, S. (1995). Use of R-beta-[1-11C]hydroxybutyrate in PET studies of regional cerebral uptake of ketone bodies in humans. Am. J. Physiol. 269(5 Pt 1), E948-E959.
17. Bough, K. J., Wetherington, J., Hassel, B., Pare, J. F., Gawryluk, J. W., Greene, J. G., et al. (2006). Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann. Neurol. 60, 223-235. doi: 10.1002/ana.20899
18. Bougneres, P. F., Lemmel, C., Ferre, P., and Bier, D. M. (1986). Ketone body transport in the human neonate and infant. J. Clin. Invest. 77, 42-48. doi: 10.1172/JCI112299
19. Bowen, D. M., White, P., Spillane, J. A., Goodhardt,M. J., Curzon, G., Iwangoff, P., et al. (1979). Accelerated ageing or selective neuronal loss as an important cause of dementia?. Lancet 1, 11-14.
20. Breckenridge,W. C., and Kuksis, A. (1967). Molecular weight distributions of milk fat triglycerides from seven species. J. Lipid Res. 8, 473-478.
21. Brunengraber, H., and Roe, C. R. (2006). Anaplerotic molecules: Current and future. J. Inherit. Metab. Dis. 29, 327-331. doi: 10.1007/s10545-006-0320-1
22. Burns, C. M., Chen, K., Kaszniak, A. W., Lee, W., Alexander, G. E., Bandy, D., et al. (2013). Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions. Neurology 80, 1557-1564. doi: 10.1212/WNL.0b013e31828f17
23. de Cahill, G. F. Jr. (2006). Fuel metabolism in starvation. Annu. Rev. Nutr. 26, 1-22. doi: 10.1146/annurev.nutr.26.061505.111258
24. Castellano, C. A., Baillargeon, J. P., Nugent, S., Tremblay, S., Fortier, M., Imbeault, H., et al. (2015a). Regional brain glucose hypometabolism in young women with polycystic ovary syndrom: Possible link to mild insulin resistance. PLoS ONE 10: e0144116. doi: 10.1371/journal.pone.0144116
25. Castellano, C. A., Nugent, S., Paquet, N., Tremblay, S., Bocti, C., Lacombe, G., et al. (2015b). Lower brain 18F-Fluorodeoxyglucose uptake but normal 11CAcetoacetate metabolism in mild Alzheimer’s Disease dementia. J. Alzheimers Dis. 43, 1343-1353. doi: 10.3233/JAD-141074
26. Clarke, K., Tchabanenko, K., Pawlosky, R., Carter, E., Todd King, M., Musa-Veloso, K., et al. (2012). Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. Regul. Toxicol. Pharmacol. 63, 401-408. doi: 10.1016/j.yrtph.2012.04.008
27. Courchesne-Loyer, A., Fortier, M., Tremblay-Mercier, J., Chouinard-Watkins, R., Roy, M., Nugent, S., et al. (2013). Stimulation of mild, sustained ketonemia by medium-chain triacylglycerols in healthy humans: Estimated potential contribution to brain energy metabolism. Nutrition 29, 635-640. doi: 10.1016/j.nut.2012.09.009
28. Courchesne-Loyer, A., St-Pierre, V., Hennebelle, M., Castellano, C. A., Fortier, M., Tessier, D., et al. (2015). Ketogenic response to cotreatment with bezafibrate and medium chain triacylglycerols in healthy humans. Nutrition 31, 1255-1259. doi: 10.1016/j.nut.2015.05.015
29. Craft, S. (2009). The role of metabolic disorders in Alzheimer disease and vascular dementia: Two roads converged. Arch. Neurol. 66, 300-305. doi: 10.1001/archneurol.2009.27
30. Craft, S. (2012). Alzheimer disease: Insulin resistance and AD-extending the translational path. Nat. Rev. Neurol. 8, 360-362. doi: 10.1038/nrneurol.2012.112
31. Cunnane, S., Nugent, S., Roy, M., Courchesne-Loyer, A., Croteau, E., Tremblay, S., et al. (2011). Brain fuel metabolism, aging, and Alzheimer’s disease. Nutrition 27, 3-20. doi: 10.1016/j.nut.2010.07.021
32. Cunnane, S. C., Courchesne-Loyer, A., St-Pierre, V., Vandenberghe, C., Pierotti, T., Fortier, M., et al. (2016). Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer’s disease. Ann. N. Y. Acad. Sci. 1367, 12-20. doi: 10.1111/nyas.12999
33. Cunnane, S. C., and Crawford, M. A. (2014). Energetic and nutritional constraints on infant brain development: Implications for brain expansion during human evolution. J. Hum. Evol. 77, 88-98. doi: 10.1016/j.jhevol.2014.05.001
34. Cunnane, S. C., Ryan, M. A., Nadeau, C. R., Bazinet, R. P., Musa-Veloso, K., and McCloy, U. (2003). Why is carbon from some polyunsaturates extensively recycled into lipid synthesis? Lipids 38, 477-484. doi: 10.1007/s11745-003-1087-8
35. D’Agostino, D. P., Pilla, R., Held, H. E., Landon, C. S., Puchowicz, M., Brunengraber, H., et al. (2013). Therapeutic ketosis with ketone ester delays central nervous system oxygen toxicity seizures in rats Am. J. Physiol. Regul. Integr. Comp. Physiol. 304, R829-R836. doi: 10.1152/ajpregu.00506.2012
36. Dastur, D. K. (1985). Cerebral blood flow and metabolism in normal human aging, pathological aging, and senile dementia. J. Cereb. Blood Flow Metab. 5, 1-9. doi: 10.1038/jcbfm.1985.1
37. De Gaetano, A., Castagneto, M., Mingrone, G., Gangeri, G., Sganga, G., Tataranni, P. A., et al. (1994). Kinetics of medium-chain triglycerides and free fatty acids in healthy volunteers and surgically stressed patients. JPEN J. Parenter. Enteral. Nutr. 18, 134-140. doi: 10.1177/0148607194018002134
38. De Santi, S., de Leon, M. J., Convit, A., Tarshish, C., Rusinek, H., Tsui, W. H., et al. (1995). Age-related changes in brain: II. Positron emission tomography of frontal and temporal lobe glucose metabolism in normal subjects. Psychiatr. Q.Winter 66, 357-370. doi: 10.1007/BF02238755
39. DeVivo, D. C., Leckie, M. P., Ferrendelli, J. S., and McDougal, D. B. Jr. (1978). Chronic ketosis and cerebral metabolism. Ann. Neurol. 3, 331-337. doi: 10.1002/ana.410030410
40. Drenick, E. J., Alvarez, L. C., Tamasi, G. C., and Brickman, A. S. (1972). Resistance to symptomatic insulin reactions after fasting. J. Clin. Invest. 51, 2757-2762. doi: 10.1172/JCI107095
41. Ebert, D., Haller, R. G., and Walton, M. E. (2003). Energy contribution of octanoate to intact rat brain metabolism measured by 13C nuclear magnetic resonance spectroscopy. J. Neurosci. 23, 5928-5935.
42. Fery, F., and Balasse, E. O. (1983). Ketone body turnover during and after exercise in overnight-fasted and starved humans. Am. J. Physiol. 245, E318-E325.
43. Fery, F., and Balasse, E. O. (1986). Response of ketone body metabolism to exercise during transition from postabsorptive to fasted state. Am. J. Physiol. 250(5 Pt 1), E495-E501.
44. Flatt, J. P. (1972). On the maximal possible rate of ketogenesis. Diabetes Metab. Res. Rev. 21, 50-53. doi: 10.2337/diab.21.1.50
45. Freemantle, E., Vandal, M., Tremblay Mercier, J., Plourde, M., Poirier, J., and Cunnane, S. C. (2009). Metabolic response to a ketogenic breakfast in the healthy elderly. J. Nutr. Health Aging 13, 293-298. doi: 10.1007/s12603-009-0026-9
46. Freund, G., and Weinsier, R. L. (1966). Standardized ketosis in man following medium chain triglyceride ingestion. Metabolism 15, 980-991. doi: 10.1016/0026-0495(66)90046-1
47. Fukao, T., Lopaschuk, G. D., and Mitchell, G. A. (2004). Pathways and control of ketone body metabolism: On the fringe of lipid biochemistry. Prostaglandins Leukot Essent Fatty Acids 70, 243-251. doi: 10.1016/j.plefa.2003.11.001
48. Fulop, T., Dupuis, G., Baehl, S., Le Page, A., Bourgade, K., Frost, E., et al. (2015). From inflamm-aging to immune-paralysis: A slippery slope during aging for immune-adaptation. Biogerontology 17, 147-157. doi: 10.1007/s10522-015-9615-7
49. Fulop, T., Lacombe, G., Cunnane, S., Le Page, A., Dupuis, G., Frost, E. H., et al. (2013). Elusive Alzheimer’s disease: Can immune signatures help our understanding of this challenging disease? Part 2: New immune paradigm. Discov. Med. 15, 33-42.
50. Garber, A. J., Menzel, P. H., Boden, G., and Owen, O. E. (1974). Hepatic ketogenesis and gluconeogenesis in humans. J. Clin. Invest. 54, 981-989. doi: 10.1172/JCI107839
51. Garraux, G., Salmon, E., Degueldre, C., Lemaire, C., Laureys, S., and Franck, G. (1999). Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia. Neuroimage 10, 149-162. doi: 10.1006/nimg.1999.0463
52. Gibson, R. E., Burns, H. D., Hamill, T. G., Eng, W. S., Francis, B. E., and Ryan, C. (2000). Non-invasive radiotracer imaging as a tool for drug development. Curr. Pharm. Des. 6, 973-989. doi: 10.2174/1381612003399987
53. Guillot, E., Vaugelade, P., Lemarchal, P., and Rerat, A. (1993). Intestinal absorption and liver uptake of medium-chain fatty acids in non-anaesthetized pigs. Br. J. Nutr. 69, 431-442. doi: 10.1079/BJN19930045
54. Halestrap, A. P., and Price, N. T. (1999). The proton-linked monocarboxylate transporter (MCT) family: Structure, function and regulation. Biochem. J. 343(Pt 2), 281-299. doi: 10.1042/0264-6021: 3430281
55. Hall, S. E., Wastney, M. E., Bolton, T. M., Braaten, J. T., and Berman, M. (1984). Ketone body kinetics in humans: The effects of insulin-dependent diabetes, obesity, and starvation. J. Lipid Res. 25, 1184-1194.
56. Hasselbalch, S. G., Knudsen, G. M., Jakobsen, J., Hageman, L. P., Holm, S., and Paulson, O. B. (1995). Blood-brain barrier permeability of glucose and ketone bodies during short-term starvation in humans. Am. J. Physiol. 268(6 Pt 1), E1161-E1166.
57. Hasselbalch, S. G., Madsen, P. L., Hageman, L. P., Olsen, K. S., Justesen, N., Holm, S., et al. (1996). Changes in cerebral blood flow and carbohydrate metabolism during acute hyperketonemia. Am. J. Physiol. 270(5 Pt 1), E746-E751.
58. Hedden, T., and Gabrieli, J. D. (2004). Insights into the ageing mind: A view from cognitive neuroscience. Nat. Rev. Neurosci. 5, 87-96. doi: 10.1038/nrn1323
59. Henderson, S. T. (2008). Ketone bodies as a therapeutic for Alzheimer’s disease. Neurotherapeutics 5, 470-480. doi: 10.1016/j.nurt.2008.05.004
60. Henderson, S. T., Vogel, J. L., Barr, L. J., Garvin, F., Jones, J. J., and Costantini, L. C. (2009). Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: A randomized, double-blind, placebo-controlled, multicenter trial. Nutr. Metab. (Lond.) 6: 31. doi: 10.1186/1743-7075-6-31
61. Hennebelle, M., Courchesne-Loyer, A., St-Pierre, V., Vandenberghe, C., Castellano, C. A., Fortier, M., et al. (2016). Preliminary evaluation of a differential effect of an alpha-linolenate-rich supplement on ketogenesis and plasma omega-3 fatty acids in young compared to older adults. Nutrition 16, 30040-30045. doi: 10.1016/j.nut.2016.03.025
62. Herholz, K., Salmon, E., Perani, D., Baron, J. C., Holthoff, V., Frolich, L., et al. (2002). Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 17, 302-316. doi: 10.1006/nimg.2002.1208
63. Hertz, L., Chen, Y., and Waagepetersen, H. S. (2015). Effects of ketone bodies in Alzheimer’s disease in relation to neural hypometabolism, beta-amyloid toxicity, and astrocyte function. J. Neurochem. 134, 7-20. doi: 10.1111/jnc.13107
64. Hilditch, T. P., and Meara, M. L. (1944). Human-milk fat: 1. Component fatty acids. Biochem. J. 38, 29-34.
65. Hoyer, S. (1992). Oxidative energy metabolism in Alzheimer brain. Studies in early-onset and late-onset cases. Mol. Chem. Neuropathol. 16, 207-224. doi: 10.1007/BF03159971
66. Hoyer, S., Oesterreich, K., and Wagner,O. (1988). Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type? J. Neurol. 235, 143-148. doi: 10.1007/BF00314304
67. Huttenlocher, P. R. (1976). Ketonemia and seizures: Metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr. Res. 10, 536-540. doi: 10.1203/00006450-197605000-00006
68. Insull, W. Jr., and Ahrens, E. H. Jr. (1959). The fatty acids of human milk from mothers on diets taken ad libitum. Biochem. J. 72, 27-33. doi: 10.1042/bj0720027
69. Ishibashi, K., Onishi, A., Fujiwara, Y., Ishiwata, K., and Ishii, K. (2015). Relationship between Alzheimer disease-like pattern of 18F-FDG and fasting plasma glucose levels in cognitively normal volunteers. J. Nucl. Med. 56, 229-233. doi: 10.2967/jnumed.114.150045
70. Iwangoff, P., Armbruster, R., Enz, A., and Meier-Ruge, W. (1980). Glycolytic enzymes from human autoptic brain cortex: Normal aged and demented cases. Mech. Ageing Dev. 14, 203-209. doi: 10.1016/0047-6374(80)90120-7
71. Kalpouzos, G., Chetelat, G., Baron, J. C., Landeau, B., Mevel, K., Godeau, C., et al. (2009). Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol. Aging 30, 112-124. doi: 10.1016/j.neurobiolaging.2007.05.019
72. Kashiwaya, Y., Takeshima, T., Mori, N., Nakashima, K., Clarke, K., and Veech, R. L. (2000). D-beta-hydroxybutyrate protects neurons in models of Alzheimer’s and Parkinson’s disease. Proc. Natl. Acad. Sci. U.S.A. 97, 5440-5444. doi: 10.1073/pnas.97.10.5440
73. Krikorian, R., Shidler, M. D., Dangelo, K., Couch, S. C., Benoit, S. C., and Clegg, D. J. (2012). Dietary ketosis enhances memory in mild cognitive impairment Neurobiol. Aging 33, 425.e19-425.e27. doi: 10.1016/j.neurobiolaging.2010.10.006
74. Kuge, Y., Yajima, K., Kawashima, H., Yamazaki, H., Hashimoto, N., and Miyake, Y. (1995). Brain uptake and metabolism of [1-11C]octanoate in rats: Pharmacokinetic basis for its application as a radiopharmaceutical for studying brain fatty acid metabolism. Ann. Nucl. Med. 9, 137-142. doi: 10.1007/BF03165040
75. Lapointe, E., Deacon, C., Royer-Perron, L., Cunnane, S. C., Castellano, C. A., and Bocti, C. (2016). Temporal lobe atrophy may be underrecognized in older patients with new-onset epilepsy. Can. J. Neurol. Sci. (in press). London, E. D.
76. Margolin, R. A., Duara, R., Holloway, H. W., Robertson-Tchabo, E. A., Cutler, N. R., et al. (1986). Effects of fasting on ketone body concentrations in healthy men of different ages. J. Gerontol. 41, 599-604. doi: 10.1093/geronj/41.5.599
77. Lying-Tunell, U., Lindblad, B. S., Malmlund, H. O., and Persson, B. (1981). Cerebral blood flow and metabolic rate of oxygen, glucose, lactate, pyruvate, ketone bodies and amino acids. Acta Neurol. Scand. 63, 337-350. doi: 10.1111/j.1600-0404.1981.tb00788.x
78. Maalouf, M., Rho, J. M., andMattson, M. P. (2009). The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res. Rev. 59, 293-315. doi: 10.1016/j.brainresrev.2008.09.002
79. Mamelak, M. (2012). Sporadic Alzheimer’s disease: The starving brain. J. Alzheimers Dis. 31, 459-474. doi: 10.3233/JAD-2012-120370
80. Matsuzaki, T., Sasaki, K., Tanizaki, Y., Hata, J., Fujimi, K., Matsui, Y., et al. (2010). Insulin resistance is associated with the pathology of Alzheimer disease: The Hisayama study. Neurology 75, 764-770. doi: 10.1212/WNL.0b013e3181eee25f
81. Meier-Ruge, W., Iwangoff, P., and Bertoni-Freddari, C. (1994). What is primary and what secondary for amyloid deposition in Alzheimer’s disease. Ann. N. Y. Acad. Sci. 719, 230-237. doi: 10.1111/j.1749-6632.1994.tb56831.x
82. Meier-Ruge, W. A., and Bertoni-Freddari, C. (1997). Pathogenesis of decreased glucose turnover and oxidative phosphorylation in ischemic and traumainduced dementia of the Alzheimer type. Ann. N. Y. Acad. Sci. 826, 229-241. doi: 10.1111/j.1749-6632.1997.tb48474.x
83. Mitchell, G. A., Kassovska-Bratinova, S., Boukaftane, Y., Robert,M. F., Wang, S. P., Ashmarina, L., et al. (1995). Medical aspects of ketone body metabolism. Clin. Invest. Med. 18, 193-216.
84. Mochel, F., DeLonlay, P., Touati, G., Brunengraber, H., Kinman, R. P., Rabier, D., et al. (2005). Pyruvate carboxylase deficiency: Clinical and biochemical response to anaplerotic diet therapy. Mol. Genet. Metab. 84, 305-312. doi: 10.1016/j.ymgme.2004.09.007
85. Mochel, F., Duteil, S., Marelli, C., Jauffret, C., Barles, A., Holm, J., et al. (2010). Dietary anaplerotic therapy improves peripheral tissue energy metabolism in patients with Huntington’s disease. Eur. J. Hum. Genet. 18, 1057-1060. doi: 10.1038/ejhg.2010.72
86. Moeller, J. R., Ishikawa, T., Dhawan, V., Spetsieris, P.,Mandel, F., Alexander, G. E., et al. (1996). The metabolic topography of normal aging. J. Cereb. Blood Flow Metab. 16, 385-398. doi: 10.1097/00004647-199605000-00005
87. Mosconi, L., Sorbi, S., de Leon, M. J., Li, Y., Nacmias, B., Myoung, P. S., et al. (2006). Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer’s disease. J. Nucl. Med. 47, 1778-1786.
88. Newport, M. T., VanItallie, T. B., Kashiwaya, Y., King, M. T., and Veech, R. L. (2015). A new way to produce hyperketonemia: Use of ketone ester in a case of Alzheimer’s disease. Alzheimers Dement. 11, 99-103. doi: 10.1016/j.jalz.2014.01.006
89. Nugent, S., Castellano, C. A., Bocti, C., Dionne, I., Fulop, T., and Cunnane, S. C. (2016). Relationship of metabolic and endocrine parameters to brain glucose metabolism in older adults: Do cognitively-normal older adults have a particular metabolic phenotype? Biogerontology 17, 241-255. doi: 10.1007/s10522-015-9595-7
90. Nugent, S., Castellano, C. A., Goffaux, P., Whittingstall, K., Lepage, M., Paquet, N., et al. (2014a). Glucose hypometabolism is highly localized but lower cortical thickness and brain atrophy are widespread in cognitively normal older adults Am. J. Physiol. Endocrinol. Metab. 306, E1315-E1321. doi: 10.1152/ajpendo.00067.2014
91. Nugent, S., Tremblay, S., Chen, K. W., Ayutyanont, N., Roontiva, A., Castellano, C. A., et al. (2014b). Brain glucose and acetoacetate metabolism: A comparison of young and older adults. Neurobiol. Aging 35, 1386-1395. doi: 10.1016/j.neurobiolaging.2013.11.027
92. Ogawa, M., Fukuyama, H., Ouchi, Y., Yamauchi, H., and Kimura, J. (1996). Altered energy metabolism in Alzheimer’s disease. J. Neurol. Sci. 139, 78-82. doi: 10.1016/0022-510X(96)00033-0
93. Owen, O. E., Kalhan, S. C., and Hanson, R. W. (2002). The key role of anaplerosis and cataplerosis for citric acid cycle function. J. Biol. Chem. 277, 30409-30412. doi: 10.1074/jbc.R200006200
94. Owen, O. E., Morgan, A. P., Kemp, H. G., Sullivan, J. M., Herrera, M. G., and Cahill, G. F. Jr. (1967). Brain metabolism during fasting. J. Clin. Invest. 46, 1589-1595. doi: 10.1172/JCI105650
95. Owen, O. E., and Reichard, G. A. Jr. (1971). Human forearm metabolism during progressive starvation. J. Clin. Invest. 50, 1536-1545. doi: 10.1172/JCI106639
96. Owen, O. E., Reichard, G. A. Jr., Markus, H., Boden, G., Mozzoli, M. A., and Shuman, C. R. (1973). Rapid intravenous sodium acetoacetate infusion in man. Metabolic and kinetic responses. J. Clin. Invest. 52, 2606-2616. doi: 10.1172/JCI107453
97. Page, K. A., Williamson, A., Yu, N., McNay, E. C., Dzuira, J., McCrimmon, R. J., et al. (2009). Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia. Diabetes 58, 1237-1244. doi: 10.2337/db08-1557
98. Pailla, K., El-Mir, M. Y., Cynober, L., and Blonde-Cynober, F. (2001). Cytokinemediated inhibition of ketogenesis is unrelated to nitric oxide or protein synthesis. Clin. Nutr. 20, 313-317. doi: 10.1054/clnu.2001.0421
99. Pan, J. W., Telang, F. W., Lee, J. H., de Graaf, R. A., Rothman, D. L., Stein, D. T., et al. (2001). Measurement of beta-hydroxybutyrate in acute hyperketonemia in human brain. J. Neurochem. 79, 539-544. doi: 10.1046/j.1471-4159.2001.00575.x
100. Pascual, J. M., Liu, P., Mao, D., Kelly, D. I., Hernandez, A., Sheng, M., et al. (2014). Triheptanoin for glucose transporter type I deficiency (G1D): Modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement. JAMA Neurol. 71, 1255-1265. doi: 10.1001/jamaneurol.2014.1584
101. Perry, E. K., Perry, R. H., Tomlinson, B. E., Blessed, G., and Gibson, P. H. (1980). Coenzyme A-acetylating enzymes in Alzheimer’s disease: Possible cholinergic ‘compartment’ of pyruvate dehydrogenase. Neurosci. Lett. 18, 105-110. doi: 10.1016/0304-3940(80)90220-7
102. Petit-Taboue, M. C., Landeau, B., Desson, J. F., Desgranges, B., and Baron, J. C. (1998). Effects of healthy aging on the regional cerebral metabolic rate of glucose assessed with statistical parametric mapping. Neuroimage 7, 176-184. doi: 10.1006/nimg.1997.0318
103. Pifferi, F., Tremblay, S., Croteau, E., Fortier, M., Tremblay-Mercier, J., Lecomte, R., et al. (2011). Mild experimental ketosis increases brain uptake of (11)Cacetoacetate and (18)F-fluorodeoxyglucose: A dual-tracer PET imaging study in rats. Nutr. Neurosci. 14, 51-58. doi: 10.1179/1476830510Y.0000000001
104. Pi-Sunyer, F. X., Hashim, S. A., and Van Itallie, T. B. (1969). Insulin and ketone responses to ingestion of medium and long-chain triglycerides in man. Diabetes Metab. Res. Rev. 18, 96-100.
105. Plecko, B., Stoeckler-Ipsiroglu, S., Schober, E., Harrer, G., Mlynarik, V., Gruber, S., et al. (2002). Oral beta-hydroxybutyrate supplementation in two patients with hyperinsulinemic hypoglycemia: Monitoring of beta-hydroxybutyrate levels in blood and cerebrospinal fluid, and in the brain by in vivo magnetic resonance spectroscopy. Pediatr. Res. 52, 301-306. doi: 10.1203/00006450-200208000-00025
106. Rahman, M., Muhammad, S., Khan, M. A., Chen, H., Ridder, D. A., Muller-Fielitz, H., et al. (2014). The beta-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. Nat. Commun. 5: 3944. doi: 10.1038/ncomms4944
107. Rebello, C. J., Keller, J. N., Liu, A. G., Johnson, W. D., and Greenway, F. L. (2015). Pilot feasibility and safety study examining the effect of medium chain triglyceride supplementation in subjects with mild cognitive impairment: A randomized controlled trial. BBA Clin. 3, 123-125. doi: 10.1016/j.bbacli.2015.01.001
108. Rees, D. A., Udiawar, M., Berlot, R., Jones, D. K., and O’Sullivan, M. J. (2016). White matter microstructure and cognitive function in young women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 101, 314-323. doi: 10.1210/jc.2015-2318
109. Reger, M. A., Henderson, S. T., Hale, C., Cholerton, B., Baker, L. D., Watson, G. S., et al. (2004). Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol. Aging 25, 311-314. doi: 10.1016/S0197-4580(03)00087-3
110. Reichard, G. A. Jr., Owen, O. E., Haff, A. C., Paul, P., and Bortz, W. M. (1974). Ketone-body production and oxidation in fasting obese humans. J. Clin. Invest. 53, 508-515. doi: 10.1172/JCI107584
111. Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., et al. (2004). Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer’s dementia. Proc. Natl. Acad. Sci. U.S.A. 101, 284-289. doi: 10.1073/pnas.2635903100
112. Robinson, A. M., and Williamson, D. H. (1980). Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol. Rev. 60, 143-187.
113. Roe, C. R., and Mochel, F. (2006). Anaplerotic diet therapy in inherited metabolic disease: Therapeutic potential. J. Inherit. Metab. Dis. 29, 332-340. doi: 10.1007/s10545-006-0290-3
114. Ronnemaa, E., Zethelius, B., Sundelof, J., Sundstrom, J., Degerman-Gunnarsson, M., Berne, C., et al. (2008). Impaired insulin secretion increases the risk of Alzheimer disease. Neurology 71, 1065-1071. doi: 10.1212/01.wnl.0000310646.32212.3a
115. Roy, M., Beauvieux, M. C., Naulin, J., El Hamrani, D., Gallis, J. L., Cunnane, S. C., et al. (2015). Rapid adaptation of rat brain and liver metabolism to a ketogenic diet: An integrated study using (1)H-and (13)C-NMR spectroscopy. J. Cereb. Blood Flow Metab. 35, 1154-1162. doi: 10.1038/jcbfm.2015.29
116. Roy, M., Nugent, S., Tremblay-Mercier, J., Tremblay, S., Courchesne-Loyer, A., Beaudoin, J. F., et al. (2012). The ketogenic diet increases brain glucose and ketone uptake in aged rats: A dual tracer PET and volumetric MRI study. Brain Res. 1488, 14-23. doi: 10.1016/j.brainres.2012.10.008
117. Sarda, P., Lepage, G., Roy, C. C., and Chessex, P. (1987). Storage of mediumchain triglycerides in adipose tissue of orally fed infants. Am. J. Clin. Nutr. 45, 399-405.
118. Schioth, H. B., Craft, S., Brooks, S. J., Frey, W. H. II, and Benedict, C. (2012). Brain insulin signaling and Alzheimer’s disease: Current evidence and future directions. Mol. Neurobiol. 46, 4-10. doi: 10.1007/s12035-011-8229-6
119. Scholl, M., Almkvist, O., Bogdanovic, N., Wall, A., Langstrom, B., Viitanen, M., et al. (2011). Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers. J. Alzheimers Dis. 24, 495-506. doi: 10.3233/JAD-2011-101563
120. Schrijvers, E. M., Witteman, J. C., Sijbrands, E. J., Hofman, A., Koudstaal, P. J., and Breteler, M. M. (2010). Insulin metabolism and the risk of Alzheimer disease: The rotterdam study. Neurology 75, 1982-1987. doi: 10.1212/WNL.0b013e3181ffe4f6
121. Seaton, T. B., Welle, S. L., Warenko, M. K., and Campbell, R. G. (1986). Thermic effect of medium-chain and long-chain triglycerides in man. Am. J. Clin. Nutr. 44, 630-634.
122. Settergren, G., Lindblad, B. S., and Persson, B. (1976). Cerebral blood flow and exchange of oxygen, glucose, ketone bodies, lactate, pyruvate and amino acids in infants. Acta Paediatr. Scand. 65, 343-353. doi: 10.1111/j.1651-2227.1976.tb04896.x
123. Simpson, I. A., Carruthers, A., and Vannucci, S. J. (2007). Supply and demand in cerebral energy metabolism: The role of nutrient transporters. J. Cereb. Blood Flow Metab. 27, 1766-1791. doi: 10.1038/sj.jcbfm.9600521
124. Sorbi, S., Bird, E. D., and Blass, J. P. (1983). Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann. Neurol. 13, 72-78. doi: 10.1002/ana.410130116
125. St-Onge, M. P., and Jones, P. J. (2002). Physiological effects of medium-chain triglycerides: Potential agents in the prevention of obesity. J. Nutr. 132, 329-332.
126. Swerdlow, R. H., Burns, J. M., and Khan, S. M. (2014). The Alzheimer’s disease mitochondrial cascade hypothesis: Progress and perspectives. Biochim. Biophys. Acta 1842, 1219-1231. doi: 10.1016/j.bbadis.2013.09.010
127. Swerdlow, R. H., and Khan, S. M. (2004). A "mitochondrial cascade hypothesis" for sporadic Alzheimer’s disease. Med. Hypotheses 63, 8-20. doi: 10.1016/j.mehy.2003.12.045
128. Traul, K. A., Driedger, A., Ingle, D. L., and Nakhasi, D. (2000). Review of the toxicologic properties of medium-chain triglycerides. Food Chem. Toxicol. 38, 79-98. doi: 10.1016/S0278-6915(99)00106-4
129. Tremblay, S., Ouellet, R., Rodrigue, S., Langlois, R., Benard, F., and Cunnane, S. C. (2007). Automated synthesis of 11C-acetoacetic acid, a key alternate brain fuel to glucose. Appl. Radiat. Isot. 65, 934-940. doi: 10.1016/j.apradiso.2007.03.015
130. Tremblay-Mercier, J., Tessier, D., Plourde, M., Fortier, M., Lorrain, D., and Cunnane, S. C. (2010). Bezafibrate mildly stimulates ketogenesis and fatty acid metabolism in hypertriglyceridemic subjects. J. Pharmacol. Exp. Ther. 334, 341-346. doi: 10.1124/jpet.110.166504
131. Veech, R. L., Chance, B., Kashiwaya, Y., Lardy, H. A., and Cahill, G. F. Jr. (2001). Ketone bodies, potential therapeutic uses. IUBMB Life 51, 241-247. doi: 10.1080/152165401753311780
132. Velliquette, R. A., O’Connor, T., and Vassar, R. (2005). Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: Possible early events in Alzheimer’s disease pathogenesis. J. Neurosci. 25, 10874-10883. doi: 10.1523/JNEUROSCI.2350-05.2005
133. Veneman, T., Mitrakou, A., Mokan, M., Cryer, P., and Gerich, J. (1994). Effect of hyperketonemia and hyperlacticacidemia on symptoms, cognitive dysfunction, and counterregulatory hormone responses during hypoglycemia in normal humans. Diabetes Metab. Res. Rev. 43, 1311-1317.
134. Viggiano, A., Pilla, R., Arnold, P., Monda, M., D’Agostino, D., and Coppola, G. (2015). Anticonvulsant properties of an oral ketone ester in a pentylenetetrazole-model of seizure. Brain Res. 1618, 50-54. doi: 10.1016/j.brainres.2015.05.023
135. Vossel, K. A., Beagle, A. J., Rabinovici, G. D., Shu, H., Lee, S. E., Naasan, G., et al. (2013). Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol. 70, 1158-1166. doi: 10.1001/jamaneurol.2013.136
136. Wilkins, H. M., Koppel, S., Carl, S. M., Ramanujan, S., Weidling, I., Michaelis, M. L., et al. (2016). Oxaloacetate enhances neuronal cell bioenergetic fluxes and infrastructure. J. Neurochem. 137, 76-87. doi: 10.1111/jnc.13545
137. Yao, J., Irwin, R. W., Zhao, L., Nilsen, J., Hamilton, R. T., and Brinton, R. D. (2009). Mitochondrial bioenergetic deficit precedes Alzheimer’s pathology in female mouse model of Alzheimer’s disease. Proc. Natl. Acad. Sci. U.S.A. 106, 14670-14675. doi: 10.1073/pnas.0903563106
138. Yin, J. X., Maalouf, M., Han, P., Zhao, M., Gao, M., Dharshaun, T., et al. (2016). Ketones block amyloid entry and improve cognition in an Alzheimer’s model. Neurobiol. Aging 39, 25-37. doi: 10.1016/j.neurobiolaging.2015.11.018
139. Zilberter, M., Ivanov, A., Ziyatdinova, S., Mukhtarov, M., Malkov, A., Alpar, A., et al. (2013). Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer’s disease. J. Neurochem. 125, 157-171. doi: 10.1111/jnc.12127
140. Zuendorf, G., Kerrouche, N., Herholz, K., and Baron, J. C. (2003). Efficient principal component analysis for multivariate 3D voxel-based mapping of brain functional imaging data sets as applied to FDG-PET and normal aging. Hum. Brain Mapp. 18, 13-21. doi: 10.1002/hbm.10069